LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,417.54
+3.19%Price chart
Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30
Key dataOct 30, 2026
Open$1,428.83
From 52W high+0.00%
Volume5.03M
Market cap$1.33T
P/E (TTM)45.9x
P/S (TTM)15.4x
Div yield0.47%
Key dataOct 30, 2026
Open
$1,428.83
From 52W high
+0.00%
Volume
5.03M
Market cap
$1.33T
ValuationView details →
P/E (Fwd)
32.1x
EV/EBITDA
31.1x
P/E (TTM)
45.9x
RSI (14)
78.2
MomentumView details →
1D Return
+3.19%
YTD Return
+32.36%
SummaryUpdated Sep 1, 2026
Eli Lilly and Company (NYSE:LLY) is a major American pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company has evolved from a small Indianapolis pharmacy into one of the world's largest pharmaceutical manufacturers, with a particular focus on diabetes care, oncology, immunology, and neuroscience. Lilly went public in 1972 and has established itself as a leader in innovative drug development, with recent breakthrough success in diabetes and obesity treatments that have transformed both the company's financial performance and market position in the healthcare sector.
Similar companies
Latest newsMore news →
Republican Ron Schutz, candidate for Minnesota attorney general, disclosed a stock portfolio of more than $10,000 in each of 174 companies worth at least $1.74 million, creating potential conflicts of interest with corporations the office litigates.33d agoEli Lilly will present Phase 2 results for eloraTZP, a combination of eloralintide and tirzepatide, at EASD 2026 in Milan on Sept. 30, 2026.34d agoEli Lilly will present Phase 3 results for its experimental once-weekly injection retatrutide at the EASD 2026 symposium in Milan on Sept. 30, 2026.34d ago